Tag: nasdaq:celg

November 8, 2019

Celgene Receives FDA Approval for REBLOZYL

REBLOZYL is the first FDA-approved treatment of anemia in adults with beta thalassemia that require red blood cell transfusions.
October 15, 2019

Pharma Market Update: Q3 2019 in Review

With Q3 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
August 16, 2019

Celgene Receives FDA Approval for INREBIC for Myelofibrosis

Celgene (NASDAQ:CELG) has announced that the US Food and Drug Administration (FDA) has approved INREBIC to treat adult patients with...
August 15, 2019

10 Top Drug Sales to Watch Until 2024

Drug sales are expected to top US$1 trillion by 2024, even though a number of patents are set to expire...
July 16, 2019

Biotech Market Update: Q2 2019 in Review

With Q2 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...
July 4, 2019

5 Top Biotech Stocks by Market Cap

What are the biggest names in biotechnology? We count down the five top biotech stocks based on market cap and...
July 2, 2019

5 Top Biotechnology ETFs

For investors looking for less volatility compared to stocks, here's an overview of the five largest biotechnology ETFs for consideration.